Faculty profile

Rebecca Auer

ResearcherCancer TherapeuticsUniversity of Ottawa

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Ottawa directory, so their courses may be missing. Find their university profile.

Rebecca Auer

Researcher

Cancer Therapeutics

Health Sciences

University of Ottawa

Ottawa, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2025.
Senior (last) author on 3 recent papers, a sign of leading a research group.
Principal investigator on 7 research grants (6 CIHR, 1 SSHRC), most recently in 2025.
Supervised 2 trainees who won CIHR awards, most recently in 2022.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

177

Citations

h-index

146

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

University Profile Personal Website Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Read how they describe their research on their University of Ottawa profile.

Healthcare Implementation Science Knowledge Translation Research Strategies Trust Models, Theories And Frameworks Models, Theories, And Frameworks Cancer Treatment

Latest papers

Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2025 · senior author
Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.
Thrombosis research · 2024 · senior author
A Survey Detailing Early Onset Colorectal Cancer Patient and Caregiver Experiences in Canada.
Current oncology (Toronto, Ont.) · 2024 · first author

All 25 publications

Latest funding

Building and sustaining trust in healthcare: Co-developing a compendium of equitable strategies for building, rebuilding and maintaining trust
CIHR · 2025 · Principal investigator
$956,248
STRIVE before surgery trial: a pragmatic multicenter randomized trial of Structured TRaining to Improve fitness in a Virtual Environment before surgery
CIHR · 2025 · Co-investigator
$765,001
The Canadian Prehabilitation Network Review: a living systematic review to support advanced knowledge synthesis informing prehabilitation design and evaluation
CIHR · 2025 · Co-investigator
$100,000

All 20 grants and awards

25 publications.

Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.

Girardi L, Mallick R, Wang TF, Carrier M, Auer R, PERIOP-01 investigators

European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology2025Senior author

DOI: 10.1016/j.ejso.2025.109701 PMID: 40022885

Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.

Wang TF, Mallick R, Noureldin A, Pecarskie A, Carrier M, Auer R, PERIOP-01 investigators

Thrombosis research2024Senior author

DOI: 10.1016/j.thromres.2024.109123 PMID: 39197347

A Survey Detailing Early Onset Colorectal Cancer Patient and Caregiver Experiences in Canada.

Auer R, Meszaros C, Fossouo L, Vandermeer L, Stein BD

Current oncology (Toronto, Ont.)2024First author

DOI: 10.3390/curroncol31060238 PMID: 38920722

Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.

Chung J, Negm L, Bianchi V, Stengs L, Das A, Liu ZA, Sudhaman S, Aronson M, Brunga L, Edwards M, Forster V, Komosa M, Davidson S, Lees J, Tomboc P, Samuel D, Farah R, Bendel A, Knipstein J, Schneider KW, Reschke A, Zelcer S, Zorzi A, McWilliams R, Foulkes WD, Bedgood R, Peterson L, Rhode S, Van Damme A, Scheers I, Gardner S, Robbins G, Vanan MI, Meyn MS, Auer R, Leach B, Burke C, Villani A, Malkin D, Bouffet E, Huang A, Taylor MD, Durno C, Shlien A, Hawkins C, Getz G, Maruvka YE, Tabori U, International Replication Repair Deficiency Consortium

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2023

DOI: 10.1200/jco.21.02873 PMID: 36240479

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer.

Kennecke HF, Auer R, Cho M, Dasari NA, Davies-Venn C, Eng C, Dorth J, Garcia-Aguilar J, George M, Goodman KA, Kreppel L, Meyer JE, Monzon J, Saltz L, Schrag D, Smith JJ, Zell JA, Das P, National Cancer Institute Rectal-Anal Task Force

Journal of the National Cancer Institute2023

DOI: 10.1093/jnci/djad143 PMID: 37535679

"Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.

Tennakoon G, Auer R

Brain, behavior, and immunity2023Senior author

DOI: 10.1016/j.bbi.2023.04.012 PMID: 37127226

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results.

Kennecke HF, O'Callaghan CJ, Loree JM, Moloo H, Auer R, Jonker DJ, Raval M, Musselman R, Ma G, Caycedo-Marulanda A, Simianu VV, Patel S, Pitre LD, Helewa R, Gordon VL, Neumann K, Nimeiri H, Sherry M, Tu D, Brown CJ

Journal of clinical oncology : official journal of the American Society of Clinical Oncology2023

DOI: 10.1200/jco.22.00184 PMID: 35981270

2023 Canadian Surgery Forum

Brière R, Habashi R, Merchant S, Cadili L, Alhumoud Z, Lau R, Gawad N, Valji R, Balmes PN, Tan JGK

Canadian Journal of Surgery20231 citationsOpen Access

DOI: 10.1503/cjs.014223 PMID: W4389488805

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.

Crupi MJF, Taha Z, Janssen TJA, Petryk J, Boulton S, Alluqmani N, Jirovec A, Kassas O, Khan ST, Vallati S, Lee E, Huang BZ, Huh M, Pikor L, He X, Marius R, Austin B, Duong J, Pelin A, Neault S, Azad T, Breitbach CJ, Stojdl DF, Burgess MF, McComb S, Auer R, Diallo JS, Ilkow CS, Bell JC

Frontiers in immunology2022

DOI: 10.3389/fimmu.2022.1029269 PMID: 36405739

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.

Samson A, West EJ, Carmichael J, Scott KJ, Turnbull S, Kuszlewicz B, Dave RV, Peckham-Cooper A, Tidswell E, Kingston J, Johnpulle M, da Silva B, Jennings VA, Bendjama K, Stojkowitz N, Lusky M, Prasad KR, Toogood GJ, Auer R, Bell J, Twelves CJ, Harrington KJ, Vile RG, Pandha H, Errington-Mais F, Ralph C, Newton DJ, Anthoney A, Melcher AA, Collinson F

Cancer immunology research2022

DOI: 10.1158/2326-6066.cir-21-0171 PMID: 35439304

Write to this professor

A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.

Applying for

Paper to mentionMention their CIHR grant from 2025

Subject: Prospective PhD student: Healthcare Dear Professor Auer, My name is [your name], and I am a [your current degree or role] at [your institution]. I am applying for a PhD position starting in [term and year]. I read your paper "Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial." (2025), and it connects closely to my own work on [your research topic]. [One or two sentences on what you did and what you learned.] I also saw your CIHR-funded project "Building and sustaining trust in healthcare: Co-developing a compendium of equitable strategies for building, rebuilding and maintaining trust" (2025), and I would be glad to contribute to work in that direction. Are you accepting new PhD students for [term and year]? I have attached my CV and transcripts, and I would be glad to talk at a time that suits you. Thank you for your time. Kind regards, [your name]

Something wrong or missing on this profile? Suggest a correction

Rebecca Auer

Research

Latest papers

Latest funding

Efficacy and safety of extended duration postoperative thromboprophylaxis with low molecular weight heparin among subgroups of patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.

Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.

A Survey Detailing Early Onset Colorectal Cancer Patient and Caregiver Experiences in Canada.

Genomic Microsatellite Signatures Identify Germline Mismatch Repair Deficiency and Risk of Cancer Onset.

NCI Rectal-Anal Task Force consensus recommendations for design of clinical trials in rectal cancer.

"Don't let it to air": A cautionary tale of the potential consequences of surgery of residual cancer.

Neoadjuvant Chemotherapy, Excision, and Observation for Early Rectal Cancer: The Phase II NEO Trial (CCTG CO.28) Primary End Point Results.

2023 Canadian Surgery Forum

Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.

Neoadjuvant Intravenous Oncolytic Vaccinia Virus Therapy Promotes Anticancer Immunity in Patients.

Frequent collaborators

Marc Carrier

Jean-Simon Diallo

Tzu-Fei Wang

Erin Kennedy

Husein Moloo

Justin Presseau

Sunil Patel

Nancy Baxter

Dean Fergusson

Jordan Feld

Alice Wei

Jonathan Kimmelman

Dawn Stacey

Karen Madsen

Pamela Ohashi

Jason Sutherland

Ian Mcgilvray

Nazia Selzner

Annie Huang

Alan Tinmouth

Sarvesh Logsetty

Marko Simunovic

Philip Devereaux

Mohit Bhandari

Sameer Parpia

Joanna Dionne

Cagla Eskicioglu

Bradley Allan Petrisor

James Bain

Timothy Whelan

Edward Passos

John Agzarian

Paul Engels

Ilun Yang

Dennis Hong

Ronen Avram

Bobby Shayegan

Brian Lichty

Mark Norman Levine

John Bell